Michael F. Slag’s scientific contributions

What is this page?

This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)

Impotence in Medical Clinic Outpatients
  • Article

April 1983

·

11 Reads

·

209 Citations

JAMA The Journal of the American Medical Association

Michael F. Slag

One thousand one hundred eighty men in a medical outpatient clinic were screened as to the presence of impotence. Four hundred one men (34%) were impotent, and of those, 188 (47%) chose to be examined for their problem. After a comprehensive evaluation the following diagnoses were obtained: medication effect, 25%; psychogenic, 14%; neurological, 7%; urologic, 6%; primary hypogonadism, 10%; secondary hypogonadism, 9%; diabetes mellitus, 9%; hypothyroidism, 5%; hyperthyroidism, 1%; hyperprolactinemia, 4%; miscellaneous, 4%; and unknown causes, 7%. The mean age of the impotent patients was 59.4 years, and the prevalence of alcoholism was 7%. Luteinizing hormone, follicle-stimulating hormone, testosterone, thyroxine, triiodothyronine (T3), T3 resin uptake, and prolactin studies were necessary to diagnose individual cases. We conclude that erectile dysfunction is a common and often overlooked problem in middle-aged men followed in a medical clinic. (JAMA 1983;249:1736-1740)

Citations (1)

... phosphodiesterase type 5 or PDE 5 inhibitors such as sildenafil), the following section will review those medications that have been shown to have a negative effect on erectile functioning. Men taking antihypertensive medications often report erectile dysfunction; a result that has been found in both the retrospective studies (Hogan, Wallin, & Baer, 1980;Reichgott, 1979;Slag et al., 1983) and prospective trials (Croog, Levine, Sudilovsky, Baume, & Clive, 1988;Kostis et al., 1990;Rosen, Kostis, Jekelis, & Taska, 1994;Suzuki, Tominaga, Kumagai, & Sarita, 1988), although at least one study found no adverse effects of these medications on sexual function (Broekman, Haensel, van de Ven, & Slob, 1992). Antihyperlipidemics (medications used to treat hypercholesterolemia or high cholesterol), have also been shown to reduce erectile functioning (Francis, Kusek, Nyberg, & Eggers, 2007), and there is some indication that acetylcholine-induced relaxation associated with the medical treatment of diabetes mellitus may also contribute to erectile dysfunction (Meston & Frohlich, 2000). ...

Reference:

The effects of common medications on volumetric phallometry
Impotence in Medical Clinic Outpatients
  • Citing Article

  • April 1983

JAMA The Journal of the American Medical Association

Michael F. Slag